Skip to main content
CNSP logo

CNSP · CNS Pharmaceuticals, Inc. · Short Volume

Track CNSP — free
$5.78 -0.16 (-2.69%) At close · Sep 9
Market Cap
$8.68M
Shares
1.46M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-09-09 112 0 1,037 10.8%
2026-09-08 859 0 4,476 19.2%
2026-09-04 213 70 1,064 20.0%
2026-09-03 273 1 1,078 25.3%
2026-09-02 4,719 0 6,972 67.7%
2026-09-01 501 0 1,260 39.8%
2026-08-31 1,674 0 2,145 78.0%
2026-08-28 569 0 2,553 22.3%
2026-08-27 2,326 0 5,044 46.1%
2026-08-26 121 0 972 12.5%
2026-08-25 131 0 4,380 3.0%
2026-08-24 5,465 0 14,370 38.0%
2026-08-21 801 0 7,017 11.4%
2026-08-20 97 0 3,311 2.9%
2026-08-19 1,301 0 6,741 19.3%
2026-08-18 3,083 250 10,940 28.2%
2026-08-17 780 0 2,132 36.6%
2026-08-14 3,660 0 5,645 64.8%
2026-08-13 2,446 819 3,998 61.2%
2026-08-12 4,792 1,000 8,247 58.1%
2026-08-11 1,019 1 2,323 43.9%
2026-08-10 1 0 236 0.4%
2026-08-07 244 1 980 24.9%
2026-08-06 245 0 1,101 22.2%
2026-08-05 507 0 2,166 23.4%
2026-08-04 284 0 931 30.5%
2026-08-03 1,099 0 3,316 33.1%
2026-07-31 1,466 6 3,846 38.1%
2026-07-30 1,004 11 2,015 49.8%
2026-07-29 106 3 2,619 4.0%
2026-07-28 148 100 636 23.3%
2026-07-27 304 0 1,158 26.2%
2026-07-24 1,247 0 4,522 27.6%
2026-07-23 462 0 4,430 10.4%
2026-07-22 1,722 967 4,341 39.7%
2026-07-21 953 0 10,177 9.4%
2026-07-20 3,682 0 8,293 44.4%
2026-07-17 1,153 0 4,555 25.3%
2026-07-16 1,859 6 4,861 38.2%
2026-07-15 594 0 2,125 28.0%
2026-07-14 1,201 0 2,597 46.2%
2026-07-13 1,039 0 2,095 49.6%
2026-07-10 889 0 2,890 30.8%
2026-07-09 4,702 0 6,290 74.7%
2026-07-08 2,863 664 5,716 50.1%
2026-07-07 5,103 901 8,832 57.8%
2026-07-06 588 0 7,173 8.2%
2026-07-02 2,224 0 5,425 41.0%
2026-07-01 2,189 0 3,667 59.7%
2026-06-30 3,443 100 8,117 42.4%
Showing 1–50 of 63 days
Key facts CIK 1729427 CUSIP 18978H508 13F (30d) 9 filings 9 filers Visit website Investor relations